Robert Andrew Douglas - May 15, 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Stock symbol
RMD
Transactions as of
May 15, 2023
Transactions value $
-$349,275
Form type
4
Date filed
5/16/2023, 06:07 PM
Previous filing
Apr 18, 2023
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$349K -1.5K -0.58% $232.85 255K May 15, 2023 Douglas Family Trust F1
holding RMD ResMed Common Stock 16.9K May 15, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023.
F2 Includes 55.3958 shares of ResMed stock purchased on April 28, 2023, through the ResMed Employee Stock Purchase Plan.